Skip to main content
Erschienen in: Rheumatology International 6/2010

01.04.2010 | Short Communication

Behcet’s disease associated with malignancy in Korea: a single center experience

verfasst von: Joong Kyong Ahn, Ji Min Oh, Jaejoon Lee, Eun-Mi Koh, Hoon-Suk Cha

Erschienen in: Rheumatology International | Ausgabe 6/2010

Einloggen, um Zugang zu erhalten

Abstract

The aim of this study was to determine the clinical characteristics of Behcet’s disease (BD) complicated with malignancy in Korea. Of 1,769 patients with BD in our hospital, 32 patients (1.8%, 21 in solid cancer, 11 in hematologic malignancy) developed cancer. In 10 of the 32 subjects (31.3%), malignancy was diagnosed before or concomitantly with BD. Twelve cases (37.5%) occurred within the first 2 years of disease and 9 cases (28.1%) occurred 5 years after the diagnosis of BD. Myelodysplastic syndrome (MDS) was the most common disease (n = 7) followed by thyroid cancer (n = 4), breast cancer, cervix cancer, stomach cancer, rectal cancer, hepatoma, aplastic anemia (n = 3, each), renal cell cancer, endometrial cancer, lymphoma (n = 1, each). There were no significant differences in the clinical characteristic between patients with or without malignancy. Intestinal involvement were more frequent in patients with malignancy than those without, but was not statistically significant (p = 0.083). Our results demonstrate that MDS and thyroid cancer are the most common hematologic disease and solid cancer associated with BD, respectively. Further studies will be required to ascertain the pathogenic link between BD and malignancy and the prevalence of malignancy in BD.
Literatur
1.
Zurück zum Zitat Sakane T, Takeno M, Suzuki N, Inaba G (1999) Behcet’s disease. N Engl J Med 341:1284–1291CrossRefPubMed Sakane T, Takeno M, Suzuki N, Inaba G (1999) Behcet’s disease. N Engl J Med 341:1284–1291CrossRefPubMed
2.
Zurück zum Zitat Abu-Shakra M, Guillemin F, Lee P (1993) Cancer in systemic sclerosis. Arthritis Rheum 36:460–464CrossRefPubMed Abu-Shakra M, Guillemin F, Lee P (1993) Cancer in systemic sclerosis. Arthritis Rheum 36:460–464CrossRefPubMed
3.
Zurück zum Zitat Abu-Shakra M, Gladman DD, Urowitz MB (1996) Malignancy in systemic lupus erythematosus. Arthritis Rheum 39:1050–1054CrossRefPubMed Abu-Shakra M, Gladman DD, Urowitz MB (1996) Malignancy in systemic lupus erythematosus. Arthritis Rheum 39:1050–1054CrossRefPubMed
4.
Zurück zum Zitat Hill CL, Zhang Y, Sigurgeirsson B, Pukkala E, Mellemkjaer L, Airio A, Evans SR, Felson DT (2001) Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet 357:96–100CrossRefPubMed Hill CL, Zhang Y, Sigurgeirsson B, Pukkala E, Mellemkjaer L, Airio A, Evans SR, Felson DT (2001) Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet 357:96–100CrossRefPubMed
5.
Zurück zum Zitat Pankhurst T, Savage CO, Gordon C, Harper L (2004) Malignancy is increased in ANCA-associated vasculitis. Rheumatology (Oxford) 43:1532–1535CrossRef Pankhurst T, Savage CO, Gordon C, Harper L (2004) Malignancy is increased in ANCA-associated vasculitis. Rheumatology (Oxford) 43:1532–1535CrossRef
6.
Zurück zum Zitat Cengiz M, Altundag MK, Zorlu AF, Gullu IH, Ozyar E, Atahan IL (2001) Malignancy in Behcet’s disease: a report of 13 cases and a review of the literature. Clin Rheumatol 20:239–244CrossRefPubMed Cengiz M, Altundag MK, Zorlu AF, Gullu IH, Ozyar E, Atahan IL (2001) Malignancy in Behcet’s disease: a report of 13 cases and a review of the literature. Clin Rheumatol 20:239–244CrossRefPubMed
7.
Zurück zum Zitat Kural-Seyahi E, Fresko I, Seyahi N, Ozyazgan Y, Mat C, Hamuryudan V, Yurdakul S, Yazici H (2003) The long-term mortality and morbidity of Behcet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center. Medicine (Baltimore) 82:60–76CrossRef Kural-Seyahi E, Fresko I, Seyahi N, Ozyazgan Y, Mat C, Hamuryudan V, Yurdakul S, Yazici H (2003) The long-term mortality and morbidity of Behcet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center. Medicine (Baltimore) 82:60–76CrossRef
8.
Zurück zum Zitat Kaklamani VG, Tzonou A, Kaklamanis PG (2005) Behcet’s disease associated with malignancies. Report of two cases and review of the literature. Clin Exp Rheumatol 23:S35–S41PubMed Kaklamani VG, Tzonou A, Kaklamanis PG (2005) Behcet’s disease associated with malignancies. Report of two cases and review of the literature. Clin Exp Rheumatol 23:S35–S41PubMed
9.
Zurück zum Zitat Bozi E, Katoulis AC, Stavrianeas NG (2007) Association of Behcet’s disease with hematologic malignancies. Int J Dermatol 46:333–334CrossRefPubMed Bozi E, Katoulis AC, Stavrianeas NG (2007) Association of Behcet’s disease with hematologic malignancies. Int J Dermatol 46:333–334CrossRefPubMed
10.
Zurück zum Zitat Criteria for diagnosis of Behcet’s disease (1990) International Study Group for Behcet’s Disease. Lancet 335:1078–1080 Criteria for diagnosis of Behcet’s disease (1990) International Study Group for Behcet’s Disease. Lancet 335:1078–1080
11.
Zurück zum Zitat Kaklamani VG, Sadim M, Koumantaki Y, Kaklamanis P, Pasche B (2008) Role of polymorphisms in adamantiades—Behcet’s disease. J Rheumatol 35:2376–2378CrossRefPubMed Kaklamani VG, Sadim M, Koumantaki Y, Kaklamanis P, Pasche B (2008) Role of polymorphisms in adamantiades—Behcet’s disease. J Rheumatol 35:2376–2378CrossRefPubMed
12.
Zurück zum Zitat Shin HR, Jung KW, Won YJ, Park JG, 139 KCCR-affiliated Hospitals (2004) 2002 Annual Report of the Korea Central Cancer Registry: Based on Registered Data from 139 Hospitals. Cancer Res Treat 36:103–114 Shin HR, Jung KW, Won YJ, Park JG, 139 KCCR-affiliated Hospitals (2004) 2002 Annual Report of the Korea Central Cancer Registry: Based on Registered Data from 139 Hospitals. Cancer Res Treat 36:103–114
13.
Zurück zum Zitat Fain O, Hamidou M, Cacoub P, Godeau B, Wechsler B, Paries J, Stirnemann J, Morin AS, Gatfosse M, Hanslik T, Belmatoug N, Bletry O, Cevallos R, Delevaux I, Fisher E, Hayem G, Kaplan G, Le Hello C, Mouthon L, Larroche C, Lemaire V, Piette AM, Piette JC, Ponge T, Puechal X, Rossert J, Sarrot-Reynauld F, Sicard D, Ziza JM, Kahn MF, Guillevin L, Godeau P (2007) Vasculitides associated with malignancies: analysis of sixty patients [Vasculitis and neoplasms. 14 cases]. Arthritis Rheum 57:1473–1480CrossRefPubMed Fain O, Hamidou M, Cacoub P, Godeau B, Wechsler B, Paries J, Stirnemann J, Morin AS, Gatfosse M, Hanslik T, Belmatoug N, Bletry O, Cevallos R, Delevaux I, Fisher E, Hayem G, Kaplan G, Le Hello C, Mouthon L, Larroche C, Lemaire V, Piette AM, Piette JC, Ponge T, Puechal X, Rossert J, Sarrot-Reynauld F, Sicard D, Ziza JM, Kahn MF, Guillevin L, Godeau P (2007) Vasculitides associated with malignancies: analysis of sixty patients [Vasculitis and neoplasms. 14 cases]. Arthritis Rheum 57:1473–1480CrossRefPubMed
14.
Zurück zum Zitat Ahn JK, Cha HS, Koh EM, Kim SH, Kim YG, Lee CK, Yoo B (2008) Behcet’s disease associated with bone marrow failure in Korean patients: clinical characteristics and the association of intestinal ulceration and trisomy 8. Rheumatology (Oxford) 47:1228–1230CrossRef Ahn JK, Cha HS, Koh EM, Kim SH, Kim YG, Lee CK, Yoo B (2008) Behcet’s disease associated with bone marrow failure in Korean patients: clinical characteristics and the association of intestinal ulceration and trisomy 8. Rheumatology (Oxford) 47:1228–1230CrossRef
15.
Zurück zum Zitat Kawabata H, Sawaki T, Kawanami T, Shimoyama K, Karasawa H, Fukushima T, Masaki Y, Ogawa N, Hirose Y, Ozaki K, Shimanaka K, Takase S, Ueno H, Umehara H (2006) Myelodysplastic syndrome complicated with inflammatory intestinal ulcers: significance of trisomy 8. Int Med 45:1309–1314CrossRef Kawabata H, Sawaki T, Kawanami T, Shimoyama K, Karasawa H, Fukushima T, Masaki Y, Ogawa N, Hirose Y, Ozaki K, Shimanaka K, Takase S, Ueno H, Umehara H (2006) Myelodysplastic syndrome complicated with inflammatory intestinal ulcers: significance of trisomy 8. Int Med 45:1309–1314CrossRef
Metadaten
Titel
Behcet’s disease associated with malignancy in Korea: a single center experience
verfasst von
Joong Kyong Ahn
Ji Min Oh
Jaejoon Lee
Eun-Mi Koh
Hoon-Suk Cha
Publikationsdatum
01.04.2010
Verlag
Springer-Verlag
Erschienen in
Rheumatology International / Ausgabe 6/2010
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-009-1319-3

Weitere Artikel der Ausgabe 6/2010

Rheumatology International 6/2010 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.